BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 597011)

  • 1. Induction and properties of guinea pig serum interferon. Preliminary report.
    Nolewajka E; Mikolajski K; Kapp-Burzyńska Z; Trzeciak J; Wrona M
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):623-5. PubMed ID: 597011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-hyporesponsiveness in mice in connection with dose interval and site of administration of Newcastle disease virus. Reflexion in serum complement levels.
    Rathová V; Kocisková D; Borecký L
    Acta Virol; 1975 Apr; 19(2):158-61. PubMed ID: 239563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and initial characterization of spotted souslik (Spermophilus suslicus) interferon.
    Kandefer-Szerszeń M; Kamińska T
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):451-7. PubMed ID: 6085464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related production of spotted souslik (Spermophilus suslicus) interferon.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):453-8. PubMed ID: 2471479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon induced in the hamster by subunits of "Nocardia": essay of protection against rabies (author's transl)].
    Barot-Ciorbaru R; Yokota Y; Petit JF; Chedid L; Atanasiu P
    Ann Microbiol (Paris); 1979; 130B(2):263-9. PubMed ID: 43690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swine cell systems as interferon producers. IV. Comparative studies on the correlation between virulence of different Newcastle disease virus strains and their potency as interferon inducers.
    Toneva V
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):679-81. PubMed ID: 597015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergic effects of interferon and interferon inducer against ectromelia virus infection in mice.
    Imanishi J; Won SJ; Matsubara M; Nomura H; Kishida T
    Biken J; 1980 Jun; 23(2):77-81. PubMed ID: 6161603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and initial characterization of guinea pig interferon.
    Warfel AH; Stewart WE
    J Interferon Res; 1980; 1(1):19-22. PubMed ID: 6180041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline interferon response to 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166).
    Stringfellow DA; Weed Sd
    Am J Vet Res; 1977 Dec; 38(12):1963-7. PubMed ID: 596695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term culture of guinea pig tongue cells: a suitable interferon system.
    Lackovic V; Kontsek P; Svobodová J; Borecký L
    Acta Virol; 1979 Mar; 23(2):162-4. PubMed ID: 39441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between enhanced macrophage phagocytic activity and the induction of interferon by Newcastle disease virus in mice.
    Hamburg SI; Cassell GH; Rabinovitch M
    J Immunol; 1980 Mar; 124(3):1360-4. PubMed ID: 6965692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-induction in mouse spleen cells by the Newcastle disease virus (NDV) HN protein.
    Jestin V; Cherbonnel M
    Ann Rech Vet; 1991; 22(4):365-72. PubMed ID: 1725587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of interferon in interference and auto-interference elicited by Newcastle disease virus.
    Lomniczi
    Acta Microbiol Acad Sci Hung; 1975; 22(2):137-44. PubMed ID: 1168397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response in measles antibodies of the guinea-pig treated with interferon inductors.
    Sorodoc Y; Danielescu G; Cepleanu M; Cernescu C; Cajal N
    Rev Roum Virol (1972); 1973; 10(1):73-80. PubMed ID: 4709856
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation on extracellular slime from Pseudomonas aeruginosa as interferon inducer in mice.
    Cembrzyńska-Nowak M; Czarny A
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):167-76. PubMed ID: 2467636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon and humoral immune response in experimental influenza: infection with A/PR8 virus adapted to the mouse.
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):323-8. PubMed ID: 6160829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon production in Propionibacterium acnes treated mice.
    Cembrzyńska-Nowak M; Jarońska E; Zgórniak-Nowosielska I
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):217-24. PubMed ID: 2431669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumption of complement in chelated and nonchelated guinea pig serum after challenge with some viral and nonviral interferon inducers.
    Rathová V; Kocisková D; Krizanová O; Borecký L
    Acta Virol; 1976 Feb; 20(1):86-8. PubMed ID: 7949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The production of bovine interferon in foetal and adult organ cultures and in leukocytes.
    Kandefer-Szerszeń M; Szuster A; Rzeski W; Kamińska T; Kawecki Z
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):447-52. PubMed ID: 2471478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat interferons. Homologous and heterologus rat serum activity.
    Zamorska B; Kolaczkowska MK; Biernacka I; Lobodzińska M
    Arch Immunol Ther Exp (Warsz); 1977; 25(4):515-20. PubMed ID: 931553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.